No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
MMSI Merit Medical Systems
- 98.220
- +1.950+2.03%
Close Dec 20 16:00 ET
- 98.220
- 0.0000.00%
Post 16:15 ET
5.72BMarket Cap47.91P/E (TTM)
99.040High95.510Low1.45MVolume95.940Open96.270Pre Close142.14MTurnover2.55%Turnover Ratio60.63P/E (Static)58.28MShares108.07552wk High4.33P/B5.59BFloat Cap70.70052wk Low--Dividend TTM56.90MShs Float108.075Historical High--Div YieldTTM3.67%Amplitude1.089Historical Low98.132Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $127
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $109
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)
Merit Medical Systems Says Wrapsody Endoprosthesis Receives FDA Premarket Approval
Express News | Merit Medical Systems Inc - to Begin Commercialization of Wrapsody in USA in 2025
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
Heat List
US
Overall
Symbol
Price
% Chg
No Data